Login / Signup

Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture.

Eva G ÁlvarezJonas DemeulemeesterPaula OteroClemency JollyDaniel Garcia SoutoAna Pequeño-ValtierraJorge ZamoraMarta TojoJavier TemesAdrian Baez-OrtegaBernardo Rodriguez-MartinAna OitabenAlicia L BruzosMónica Martínez-FernándezKerstin HaaseSonia ZumalaveRosanna AbalJorge Rodríguez-CastroAitor Rodríguez-CasanovaAngel Diaz-LagaresYilong LiKeiran M RaineAdam P ButlerIago OteroAtsushi OnoHiroshi AikataKazuaki ChayamaMasaki UenoShinya HayamiHiroki YamaueKazuhiro MaejimaMiguel G BlancoXavier FornsCarmen RivasJuan Ruiz-BañobreSofía Pérez-Del-PulgarRaul Torres-RuízSandra Rodríguez-PeralesUrtzi GaraigortaPeter J CampbellHidewaki NakagawaPeter Van LooJose M C Tubio
Published in: Nature communications (2021)
Most cancers are characterized by the somatic acquisition of genomic rearrangements during tumour evolution that eventually drive the oncogenesis. Here, using multiplatform sequencing technologies, we identify and characterize a remarkable mutational mechanism in human hepatocellular carcinoma caused by Hepatitis B virus, by which DNA molecules from the virus are inserted into the tumour genome causing dramatic changes in its configuration, including non-homologous chromosomal fusions, dicentric chromosomes and megabase-size telomeric deletions. This aberrant mutational mechanism, present in at least 8% of all HCC tumours, can provide the driver rearrangements that a cancer clone requires to survive and grow, including loss of relevant tumour suppressor genes. Most of these events are clonal and occur early during liver cancer evolution. Real-time timing estimation reveals some HBV-mediated rearrangements occur as early as two decades before cancer diagnosis. Overall, these data underscore the importance of characterising liver cancer genomes for patterns of HBV integration.
Keyphrases